Cargando…

Pediatric high-grade gliomas and the WHO CNS Tumor Classification—Perspectives of pediatric neuro-oncologists and neuropathologists in light of recent updates

BACKGROUND: The WHO Classification of Tumors of the Central Nervous System has undergone major restructuring. Molecularly defined diagnostic criteria were introduced in 2016 (revised 4th edition) and expanded in 2021 (5th edition) to incorporate further essential diagnostic molecular parameters. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gielen, Gerrit H, Baugh, Joshua N, van Vuurden, Dannis G, Veldhuijzen van Zanten, Sophie E M, Hargrave, Darren, Massimino, Maura, Biassoni, Veronica, Morales la Madrid, Andres, Karremann, Michael, Wiese, Maria, Thomale, Ulrich, Janssens, Geert O, von Bueren, André O, Perwein, Thomas, Nussbaumer, Gunther, Hoving, Eelco W, Niehusmann, Pitt, Gessi, Marco, Kwiecien, Robert, Bailey, Simon, Pietsch, Torsten, Andreiuolo, Felipe, Kramm, Christof M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Basic and Translational Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209749/ https://www.ncbi.nlm.nih.gov/pubmed/35733513 http://dx.doi.org/10.1093/noajnl/vdac077

Ejemplares similares

Transitioning to molecular diagnostics in pediatric high-grade glioma: experiences with the 2016 WHO classification of CNS tumors
por: Baugh, Joshua N, et al.
Publicado: (2021)

DIPG-77. TREATMENT EXTENT AND THE EFFECT ON SURVIVAL IN DIFFUSE INTRINSIC PONTINE GLIOMA
por: Baugh, Joshua, et al.
Publicado: (2020)

EPID-01. Differences in first-line treatment but comparable survival outcomes for pediatric brainstem and non-brainstem high-grade gliomas in the Netherlands – a population-based study
por: Hoogendijk, Raoull, et al.
Publicado: (2022)

How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
por: Perwein, Thomas, et al.
Publicado: (2023)

HGG-29. How I treat recurrent pediatric high-grade glioma (HGG): A Europe-wide survey study.
por: Perwein, Thomas, et al.
Publicado: (2022)

Sex-related incidence and survival differences in pediatric high-grade glioma subtypes: A population-based cohort study
por: Hoogendijk, Raoull, et al.
Publicado: (2023)

Pediatric brain tumors: A neuropathologist's approach to the integrated diagnosis
por: Viaene, Angela N.
Publicado: (2023)

HGG-09. GLIOMATOSIS CEREBRI IN CHILDREN: A POOR PROGNOSTIC, HIGHLY INFILTRATIVE PHENOTYPE OF DIFFUSE PEDIATRIC HIGH-GRADE GLIOMAS WITH DISTINCT MOLECULAR FEATURES
por: Nussbaumer, Gunther, et al.
Publicado: (2023)

EPID-18. TRENDS IN INCIDENCE AND SURVIVAL OF MALIGNANT PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS IN THE NETHERLANDS
por: Hoogendijk, Raoull, et al.
Publicado: (2020)

DIPG-84. COMPLEMENTARY AND ALTERNATIVE MEDICINE IN DIFFUSE INTRINSIC PONTINE GLIOMA
por: El-Khouly, Fatma, et al.
Publicado: (2020)

HGG-58. SIOPE HGG Working Group approach to obtain consensus on management of paediatric high grade glioma across Europe
por: Giraud, Géraldine, et al.
Publicado: (2022)

HGG-16. Final analysis of the HIT-HGG-2007 trial (ISRCTN19852453): Significant survival benefit for pontine and non-pontine pediatric high-grade gliomas in comparison to previous HIT-GBM-C/-D trials.
por: von Bueren, Andrè O, et al.
Publicado: (2022)

State of affairs in use of steroids in diffuse intrinsic pontine glioma: an international survey and a review of the literature
por: Veldhuijzen van Zanten, Sophie E. M., et al.
Publicado: (2016)

INSP-16. Focused ultrasound-mediated blood-brain barrier disruption for the treatment of pediatric high-grade glioma
por: van Vuurden, Dannis, et al.
Publicado: (2022)

Neuropathology of COVID‐19: where are the neuropathologists?
por: Glatzel, Markus
Publicado: (2020)

Neurological Symptom Improvement After Re-Irradiation in Patients With Diffuse Intrinsic Pontine Glioma: A Retrospective Analysis of the SIOP-E-HGG/DIPG Project
por: Chavaz, Lara, et al.
Publicado: (2022)

Glioblastoma Stem Cells: A Neuropathologist's View
por: McLendon, Roger E., et al.
Publicado: (2011)

Processing of nerve biopsies: A practical guide for neuropathologists
por: Weis, Joachim, et al.
Publicado: (2012)

What Every Neuropathologist Needs to Know: The Muscle Biopsy
por: Nix, James S, et al.
Publicado: (2020)

What Every Neuropathologist Needs to Know: The Muscle Biopsy
Publicado: (2020)

DDEL-05. BLOOD-BRAIN BARRIER DISRUPTION AND ENHANCED RADIOSENSITIZERS EXTRAVASATION UPON FOCUSED ULTRASOUND FOR TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA
por: Hart, Elvin ‘t, et al.
Publicado: (2020)

Survival rates of children and young adolescents with CNS tumors improved in the Netherlands since 1990: A population-based study
por: Hoogendijk, Raoull, et al.
Publicado: (2021)

The fifth edition of the World Health Organization Classification of Tumors of the Central Nervous System: Implications for cancer registries
por: Hoogendijk, Raoull, et al.
Publicado: (2022)

Magnetic Resonance Imaging Characteristics of Molecular Subgroups in Pediatric H3 K27M Mutant Diffuse Midline Glioma
por: Hohm, Annika, et al.
Publicado: (2021)

A tribute to John Q. Trojanowski (1946–2022), neuropathologist extraordinaire
por: Goedert, Michel, et al.
Publicado: (2022)

Franz Nissl (1860-1919), noted neuropsychiatrist and neuropathologist, staining the neuron, but not limiting it
por: Gomes, Marleide da Mota
Publicado: (2019)

Effective Drug Delivery in Diffuse Intrinsic Pontine Glioma: A Theoretical Model to Identify Potential Candidates
por: El-Khouly, Fatma E., et al.
Publicado: (2017)

Reporting pediatric brain tumors according to their behavior code can result in biased survival estimates—A European perspective to Girardi et al
por: Hoogendijk, Raoull, et al.
Publicado: (2022)

PATH-11. PROSPECTIVE (EPI-)GENETIC CLASSIFICATION OF > 1,000 PEDIATRIC CNS TUMORS—THE MNP 2.0 STUDY
por: Sturm, Dominik, et al.
Publicado: (2020)

DIPG-33. CHARACTERIZING THE NEURO-VASCULAR UNIT IN DIFFUSE INTRINSIC PONTINE GLIOMA
por: El-Khouly, Fatma E, et al.
Publicado: (2020)

Psychosocial profile of pediatric brain tumor survivors with neurocognitive complaints
por: de Ruiter, Marieke Anna, et al.
Publicado: (2015)

Blood-brain barrier permeability following conventional photon radiotherapy – A systematic review and meta-analysis of clinical and preclinical studies
por: Hart, Elvin't, et al.
Publicado: (2022)

SWK-02. Palliative sedation in pediatric patients suffering from brain tumors: choosing the best drugs to improve end of life
por: Podda, Marta, et al.
Publicado: (2022)

A microRNA Prognostic Signature in Patients with Diffuse Intrinsic Pontine Gliomas through Non-Invasive Liquid Biopsy
por: Iannó, Maria F., et al.
Publicado: (2022)

Deceptive morphologic and epigenetic heterogeneity in diffuse intrinsic pontine glioma
por: Bugiani, Marianna, et al.
Publicado: (2017)

External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry
por: Veldhuijzen van Zanten, Sophie E. M., et al.
Publicado: (2017)

Microglia in pediatric brain tumors: The missing link to successful immunotherapy
por: du Chatinier, Aimée, et al.
Publicado: (2023)

Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?
por: El-Khouly, Fatma E., et al.
Publicado: (2019)

A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma
por: El-Khouly, Fatma E., et al.
Publicado: (2021)

(18) F-FDG PET standard uptake values of the normal pons in children: establishing a reference value for diffuse intrinsic pontine glioma
por: Jansen, Marc H A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_731c3hbu20gu52gkn0v0d0vmim